SETH LERNER to Neovascularization, Pathologic
This is a "connection" page, showing publications SETH LERNER has written about Neovascularization, Pathologic.
Connection Strength
0.157
-
Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model. Urol Oncol. 2009 Jul-Aug; 27(4):391-9.
Score: 0.067
-
Molecular markers in bladder cancer. Curr Opin Urol. 2008 Jan; 18(1):1-8.
Score: 0.065
-
The preclinical activity of lenalidomide in indolent urothelial carcinoma. Anticancer Res. 2014 Jul; 34(7):3383-9.
Score: 0.025